Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...

Full description

Bibliographic Details
Main Authors: Lizhong Du, Xiaomei Tong, Chao Chen, Xirong Gao, Alessandra Gagnatelli, Jingyang Li, Debora Santoro, Sara Nicolardi, Laura Fabbri, The Peyona Chinese Study Group
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Pediatrics
Subjects:
infant
newborn
drug therapy
bodyweight
apnea
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00076/full

Internet

https://www.frontiersin.org/article/10.3389/fped.2020.00076/full

Similar Items